Renflexis
Renflexis ingredients
| Active ingredient | Strength |
|---|---|
| Infliximab | 100 mg/1 |
What Renflexis is used for
The FDA lists the approved uses on the official label (below). In the EU, infliximab is approved as Remicade for:
Rheumatoid arthritis Remicade, in combination with methotrexate, is indicated for the reduction of signs and symptoms as well as the improvement in physical function in: adult patients with active disease when the response to disease-modifying antirheumatic drugs (DMARDs), including methotrexate, has been inadequate; adult patients with severe, active and progressive disease not previously treated with methotrexate or other DMARDs. In these patient populations, a reduction in the rate of the progression of joint damage, as measured by X-ray, has been demonstrated. Adult Crohn's disease Remicade is indicated for: treatment of moderately to severely active Crohn's disease, in adult patients who have not responded despite a full and adequate course of therapy with a corticosteroid and / or an immunosuppressant; or who are intolerant to or have medical contraindications for such therapies; t…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Renflexis
- Generic name
- Infliximab
- Made by
- Organon LLC
- Forms
- Injection, Powder, Lyophilized, For Solution
- Given
- Intravenous
- Drug class
- Tumor Necrosis Factor Blocker
- FDA approval
- Biologic licence (BLA) BLA761054
- On the US market since
- 2017
Official information
- Renflexis prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Infliximab)
In India
- Infliximab: 2 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Renflexis?
Renflexis (Infliximab) is a specialist medicine made by Organon LLC, approved by the US FDA.
What are the ingredients of Renflexis?
Renflexis contains Infliximab (100 mg/1).
Is Renflexis approved in Europe?
The same active substance is approved in the EU as Remicade.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA